Collegium Pharmaceutical, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $1.14B
Liabilities Breakdown FY2023
Total Liabilities: $947.9M
Asset Breakdown
Total Assets: $1.14B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $238.9M | 20.9% |
| Accounts Receivable | $179.5M | 15.7% |
| Inventory | $32.3M | 2.8% |
| Property, Plant & Equipment | $16.0M | 1.4% |
| Goodwill | $133.9M | 11.7% |
| Intangible Assets | $421.7M | 36.9% |
| Other Assets | $121.0M | 10.6% |
Liabilities Breakdown
Total Liabilities: $947.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.7M | 0.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $939.2M | 99.1% |